Celebrating 25 Years of Innovation Speaker Series with Dr. Steven Galson

About the Speaker

• Dr. Steven Galson

  

  Steven Galson, MD, MPH
  Former Senior Vice President, Amgen, and acting Surgeon General of the United States, 2007-2009

  Steven K. Galson, MD, MPH, is a senior advisor at BCG and serves as Independent Director on the Boards of Biocryst Pharmaceuticals and Elephas Biosciences. Until June 2020, he was a senior vice president of Research and Development at Amgen. He joined the company in 2010 as vice president of Global Regulatory Affairs. Prior to Amgen, Dr. Galson was senior vice president for Civilian Health Operations and chief health scientist at Science Applications International Corporation.

  Galson spent more than 20 years in government service, including two years as acting Surgeon General of the United States. Previously, he served as director of the FDA’s Center for Drug Evaluation and Research (CDER), where he provided leadership for the center’s broad national and international programs in pharmaceutical regulation.

  Dr. Galson began his public health service career as an epidemiological investigator at the Centers for Disease Control and Prevention (CDC) after completing a residency in internal medicine at the Hospitals of the Medical College of Pennsylvania. He also held senior-level positions at the Environmental Protection Agency; the Department of Energy, where he was a chief medical officer; and the Department of Health and Human Services.

  Dr. Galson holds a bachelor’s degree from Stony Brook University, an MD from Mt. Sinai School of Medicine, and an MPH from the Harvard School of Public Health. Dr. Galson is a Trustee of the Keck Graduate Institute and a founding Governor of the KGI School of Community Medicine. In 2008, he received an Honorary Doctor of Public Service degree from Drexel University School of Public Health, and in 2015, he received the Jacobi Medallion Award from Icahn Mount Sinai School of Medicine. In 2018, he was named Health Leader of the Year by the Commissioned Officers Association of the United States Public Health Service. Dr. Galson is on the Executive Committee of the Clinical Trial Transformation Initiative and is a Member of the Forum on Drug Discovery, Development, and Translation at the National Academy of Medicine.